Nyxoah SA ROE 2021-2025 | NYXH
Current and historical return on equity (ROE) values for Nyxoah SA (NYXH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Nyxoah SA ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.08B | $0.10B | -64.52% |
| 2024-12-31 | $-0.06B | $0.12B | -55.41% |
| 2024-09-30 | $-0.06B | $0.12B | -52.13% |
| 2024-06-30 | $-0.05B | $0.13B | -41.96% |
| 2024-03-31 | $-0.05B | $0.10B | -42.25% |
| 2023-12-31 | $-0.05B | $0.11B | -38.84% |
| 2023-09-30 | $-0.05B | $0.12B | -38.81% |
| 2023-06-30 | $-0.05B | $0.13B | -36.08% |
| 2023-03-31 | $-0.04B | $0.13B | -28.04% |
| 2022-12-31 | $-0.03B | $0.13B | -23.24% |
| 2022-03-31 | $-0.02B | $0.16B | -16.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.274B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.234B | 52.81 |
| Hims & Hers Health (HIMS) | United States | $12.982B | 134.88 |
| Tempus AI (TEM) | United States | $10.012B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.465B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.309B | 67.32 |
| Privia Health (PRVA) | United States | $2.902B | 198.33 |
| Enovis (ENOV) | United States | $1.848B | 10.30 |
| Clover Health Investments (CLOV) | United States | $1.791B | 0.00 |
| Schrodinger (SDGR) | United States | $1.498B | 0.00 |
| Phreesia (PHR) | United States | $1.456B | 0.00 |
| Omnicell (OMCL) | United States | $1.281B | 22.59 |
| Azenta (AZTA) | United States | $1.258B | 58.47 |
| 10x Genomics (TXG) | United States | $1.024B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.534B | 0.00 |
| Talkspace (TALK) | United States | $0.486B | 145.25 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Claritev (CTEV) | United States | $0.473B | 0.00 |
| Standard BioTools (LAB) | United States | $0.395B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 805.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.141B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| 111 (YI) | China | $0.067B | 0.00 |
| Outset Medical (OM) | United States | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |